Citation Export
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Sung Hwa | - |
dc.contributor.author | Lee, Eunhwa | - |
dc.contributor.author | Cho, Duk Yeon | - |
dc.contributor.author | Ko, Hyun Myung | - |
dc.contributor.author | Baek, Ha Yeon | - |
dc.contributor.author | Choi, Dong Kug | - |
dc.contributor.author | Kim, Eunha | - |
dc.contributor.author | Park, Ju Young | - |
dc.date.issued | 2021-03-15 | - |
dc.identifier.uri | https://dspace.ajou.ac.kr/dev/handle/2018.oak/31805 | - |
dc.description.abstract | Based on our previous report that 3-morpholino-1-phenylpropan-1-one 2, one of the fluoxetine's simplified morpholino analogue, inhibited nitric oxide (NO) production, in this paper, various substituted benzene analogues with morpholine hydrochloride of 2 were synthesized and their inhibitory effects on NO production in lipopolysaccharide (LPS)-induced BV2 cells were tested. Among the synthesized compounds, 2-trifluoromethyl analogue 16n (IC50 = 8.6 μM) showed a significantly higher inhibitory activity than that of the parent compound 2a (IC50 > 50 μM) and suppressed NO production dose-dependently without cytotoxicity. Compound 16n also inhibited iNOS expression in LPS-induced BV2 cells at 2, 10 and 20 μM concentrations. These results suggest that compound 16n inhibited NO production by suppressing the expression of iNOS and can be used as a lead structure for developing new inhibitor of NO production. | - |
dc.description.sponsorship | This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education [ NRF-2020R1A2B5B02002032 (to S.-H Yoon and D.-K Choi) and ( NRF-2020R1I1A1A01062002 and 2019R1A6A1A11051471 (to J.-Y Park)]. | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier Ltd | - |
dc.subject.mesh | Animals | - |
dc.subject.mesh | Cell Line | - |
dc.subject.mesh | Chlorides | - |
dc.subject.mesh | Dose-Response Relationship, Drug | - |
dc.subject.mesh | Lipopolysaccharides | - |
dc.subject.mesh | Mice | - |
dc.subject.mesh | Molecular Structure | - |
dc.subject.mesh | Morpholines | - |
dc.subject.mesh | Nitric Oxide | - |
dc.subject.mesh | Structure-Activity Relationship | - |
dc.title | Synthesis of 4-(3-oxo-3-phenylpropyl)morpholin-4-ium chloride analogues and their inhibitory activities of nitric oxide production in lipopolysaccharide-induced BV2 cells | - |
dc.type | Article | - |
dc.citation.title | Bioorganic and Medicinal Chemistry Letters | - |
dc.citation.volume | 36 | - |
dc.identifier.bibliographicCitation | Bioorganic and Medicinal Chemistry Letters, Vol.36 | - |
dc.identifier.doi | 10.1016/j.bmcl.2021.127780 | - |
dc.identifier.pmid | 33422605 | - |
dc.identifier.scopusid | 2-s2.0-85099921614 | - |
dc.identifier.url | http://www.journals.elsevier.com/bioorganic-and-medicinal-chemistry-letters/ | - |
dc.subject.keyword | 3-Morpholino-1-phenylpropan-1-one analogues | - |
dc.subject.keyword | BV2 cell | - |
dc.subject.keyword | NO production | - |
dc.description.isoa | false | - |
dc.subject.subarea | Biochemistry | - |
dc.subject.subarea | Molecular Medicine | - |
dc.subject.subarea | Molecular Biology | - |
dc.subject.subarea | Pharmaceutical Science | - |
dc.subject.subarea | Drug Discovery | - |
dc.subject.subarea | Clinical Biochemistry | - |
dc.subject.subarea | Organic Chemistry | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.